Status:
COMPLETED
Subjective Well Being of Schizophrenic Patients in Greece
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
Non-interventional study aiming to provide data on the subjective effects of antipsychotic medication assessing subjective well-being and global functioning of patients with Schizophrenia under antips...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Diagnosis of schizophrenia according to DSM-IV
- The patient must have been prescribed an atypical antipsychotic for at least 4 weeks before the first study visit
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00857064
Start Date
March 1 2009
End Date
October 1 2009
Last Update
December 9 2010
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Agrinio, Greece
2
Research Site
Alexsandroupoli, Greece
3
Research Site
Argos, Greece
4
Research Site
Arta, Greece